Dihydropyridine Receptor-ryanodine Receptor Uncoupling in Aged Skeletal Muscle
Overview
Authors
Affiliations
The mechanisms underlying skeletal muscle functional impairment and structural changes with advanced age are only partially understood. In the present study, we support and expand our theory about alterations in sarcolemmal excitation-sarcoplasmic reticulum Ca2+ release-contraction uncoupling as a primary skeletal muscle alteration and major determinant of weakness and fatigue in mammalian species including humans. To test the hypothesis that the number of RYR1 (ryanodine receptor) uncoupled to DHPR (dihydropyridine receptor) increases with age, we performed high-affinity ligand binding studies in soleus, extensor digitorum longus (EDL) and in a pool of several skeletal muscles consisting of a mixture of fast- and slow-twitch muscle fibers in middle-aged (14-month) and old (28-months) Fisher 344 Brown Norway F1 hybrids rats. The number of DHPR, RYR1, the coupling between both receptors expressed as the DHPR/RYR1 maximum binding capacity, and their dissociation constant for high-affinity ligands were measured. The DHPR/RYR1 ratio was significantly reduced in the three groups of muscles (pool: 1.03 +/- 0.15 and 0.80 +/- 0.11, soleus: 0.44 +/- 0. 12 and 0.26 +/- 0.10, and EDL: 0.95 +/- 0.14 and 0.68 +/- 0.10, for middle-aged and old muscles, respectively). These data support the concept that DHPR-RYR1 uncoupling results in alterations in the voltage-gated sarcoplasmic reticulum Ca2+ release mechanism, decreases in myoplasmic Ca2+ elevation in response to sarcolemmal depolarization, reduced Ca2+ supply to contractile proteins and reduced contraction force with aging.
An aged-related structural study of DHPR tetrads in peripheral couplings of human skeletal muscle.
Pietrangelo L, Mancinelli R, Fulle S, Boncompagni S Eur J Transl Myol. 2024; 34(4.
PMID: 39470322 PMC: 11726306. DOI: 10.4081/ejtm.2024.13273.
Ablation of skeletal muscle estrogen receptor alpha impairs contractility in male mice.
Sullivan B, Collins B, McMillin S, Toussaint E, Stein C, Spangenburg E J Appl Physiol (1985). 2024; 136(4):764-773.
PMID: 38328824 PMC: 11286273. DOI: 10.1152/japplphysiol.00714.2023.
Understanding the development of sarcopenic obesity.
Gross D, Cheever C, Batsis J Expert Rev Endocrinol Metab. 2023; 18(6):469-488.
PMID: 37840295 PMC: 10842411. DOI: 10.1080/17446651.2023.2267672.
Global phosphoproteomic profiling of skeletal muscle in ovarian hormone-deficient mice.
Peyton M, Yang T, Higgins L, Markowski T, Vue C, Parker L Physiol Genomics. 2022; 54(11):417-432.
PMID: 36062884 PMC: 9639773. DOI: 10.1152/physiolgenomics.00104.2022.
Noda Y, Okada S, Suzuki T Nat Commun. 2022; 13(1):2503.
PMID: 35523818 PMC: 9076623. DOI: 10.1038/s41467-022-30181-2.